Bank of New York Mellon
CLCD

Bank of New York Mellon’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Bank of New York Mellon’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-27,930
Closed -$1.02M – 4373
2016
Q4 		$1.02M Sell
27,930
-9,756
-26% -$345K ﹤0.01% 3257
2016
Q3 		$1.44M Buy
+37,686
New +$557K ﹤0.01% 2971

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Bank of New York Mellon's CLCD Position: Q1 2017 in Review

Bank of New York Mellon sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 27,930 shares — an estimated $1.02M sold.

Bank of New York Mellon first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $1.44M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Bank of New York Mellon reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 27,930 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.02M.
  • Bank of New York Mellon first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Bank of New York Mellon's CoLucid Pharmaceuticals, Inc. position peaked at $1.44M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Bank of New York Mellon's 13F filing for Q1 2017, filed 3 May 2017.